United Kingdom · Ageing Society, Health & Nutrition
Spectre Bio Ltd
Spectre Bio Ltd is a UK early-stage company with 2 public funding or programme announcements on record, most recently 1 Sep 2026.
Announcements
Innovate UK funding awarded
£95,152 · Innovation Loans; “CMC Development of a Novel Bacteria-Like Particle Immunoprophylactic for Recurrent UTI”; South East
Innovate UK funding awarded
£59,999 · Collaborative R&D grant; “Engineering a Thermostable Bacterial-like Particles (BLiPs) as a Cold-Chain Independent Re”; South East
Is this your company?
Everything here comes from the public announcement or open dataset linked above. If something is wrong or out of date, or you would rather not be listed, email hello@capitalsignals.uk.
Not a recommendation
Support or selection by Innovate UK is not a sign that the company is a good investment. Most early-stage companies cannot be invested in by the public, and many fail.